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Bacteriophage-based diagnostics and therapeutics have been 
recognized as tools to combat bacterial infections for nearly a century. Wip1 is 
a recently isolated phage that infects Bacillus anthracis, the notorious biothreat 
pathogen and gram-positive bacterium that causes anthrax disease. The 
current standard for identifying suspected B. anthracis involves testing for Wγ 
phage sensitivity. However, studies have shown that the narrow Wip1 host 
range is even more specific to B. anthracis than that of Wγ, suggesting that 
Wip1 may be a superior diagnostic tool.  
Wip1’s high specificity to B. anthracis is likely mediated by the initial 
recognition and binding of the virus to the host cell. Most bacteriophages 
interact with bacterial surfaces using tail fibers, but Wip1 is a tailless phage 
possessing an icosahedral protein coat covering an internal lipid membrane. 
These features indicate that Wip1 belongs to the family Tectiviridae, a 
relatively rare phage group with a proposed evolutionary lineage to the 
mammalian adenovirus. Tectiviruses possess protruding spike complexes at 
their vertices that are responsible for host recognition and binding. 
	  
	  
Based on adsorption assays, we confirmed that Wip1’s host range 
specificity is mediated by its receptor-binding ligand. In order to predict 
candidate gene products for the Wip1 spike complex, we sequenced the Wip1 
genome and conducted extensive genomic analyses with other tectiviral 
genomes. Observations from subsequent recombinant Wip1 protein 
expression and purification indicated that Wip1 p23 and p24 form a stable 
complex. We identified the unique protein Wip1 p23 as a receptor-binding 
protein using competitive inhibition and antibody neutralization assays. From 
indirect immunofluorescence microscopy, we also demonstrated that Wip1 
p23 binds very specifically to the surface of B. anthracis. Finally, we 
characterized the bacterial receptor for Wip1 as a Sap-dependent cell wall 
component. 
The work in this dissertation has produced a significantly more detailed 
understanding of Wip1’s highly specific tropism for B. anthracis. The findings 
that we report here also demonstrate that Wip1 phage and its receptor-binding 
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A. LITERATURE REVIEW 
 
1. Introduction 
Wip1 (for worm intestinal phage 1) is a recently identified phage that is 
of great interest for two main reasons. First, Wip1 offers promise as a 
biodefense tool. It is highly specific against Bacillus anthracis, the notorious 
biothreat agent and gram-positive bacterium responsible for anthrax disease. 
Host range analysis has demonstrated that Wip1 is even more specific for B. 
anthracis than the current diagnostic standard Wγ phage [1]. Secondly, Wip1 
belongs to the family Tectiviridae, a relatively rare and unusual group of phage 
that shares a surprising evolutionary lineage with the mammalian adenovirus. 
The tectiviral vertex spike complexes are of particular interest for both their 
structural similarities to adenovirus vertex spikes and their role in host 
recognition [2-4]. For these reasons, my dissertation focused on characterizing 









Viruses are obligatory parasites that depend on their host organisms to 
support replication. Bacteriophage (“eaters of bacteria”), or phage for short, 
are viruses that infect bacteria and have been reported for more than 140 
bacterial genera [5]. Phages are estimated to be the predominant biological 
entity in the biosphere [6]. They have been isolated from varied environments 
including oceans [7], Artic sea ice [8], sewage [9], forest soil [1], and the 
Sahara desert [10]. Phages have evolved to survive harsh conditions such as 
extreme temperatures up to 95C in hot springs [11] and pH values as low as 
1.3 [12]. 
Bacteriophage were originally discovered independently by Frederick 
Twort in 1915 and Felix d’Herelle in 1917. After d’Herelle observed that phage 
titers increased in stool samples from dysentery patients, he recognized the 
possibility of using bacteriophage as therapeutics [13]. He isolated phages for 
various bacterial diseases such as cholera, diphtheria, bubonic plague, and 
anthrax. Many, but certainly not all, early phage therapy trials appeared to be 
successful, leading to the manufacture and/or marketing of phage 
preparations by d’Herelle’s laboratory in Paris (today known as L’Oreal) and 
several pharmaceutical giants (Eli Lilly & Co, Parke-Davis, Squibb & Sons, 
and Swan-Myers division of Abbott Laboratories, etc.) [13]. Unfortunately, 
World War II and the discovery of penicillin diverted efforts away from the 
further development of phage therapy in the United States and Western 
Europe. Nonetheless, phage therapy trials continued in the former Soviet 
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Union and Eastern European countries, where phages are still regarded as a 
viable therapeutic to combat bacterial infections. 
Since their discovery, phages have been used as powerful model 
systems in molecular biology. Phage research has led to many important 
scientific discoveries [14]. For example, DNA was identified as the hereditary 
material by Hershey and Chase in 1952 based on studies conducted using 
bacteriophage T2. In another example, the study of RNA phages in the 1960’s 
provided strong support for Crick’s postulated central dogma of molecular 
biology that information flows from DNA to RNA to proteins. Phages have also 
been used in practical applications such as phage therapy [13], phage display 
[15], and diagnosis [16]. 
There are at least 13 distinct groups of phages classified by the 
International Committee on Taxonomy of Viruses (ICTV) based on virion 
morphology and nucleic acid composition. The three groups of dsDNA tailed 
phages account for 96% of all reported phages in the literature. These three 
groups differ in their tail morphology – long or short and contractile or non-
contractile. The less common phage families exhibit tailless, polyhedral, 






Table 1. ICTV classification of bacteriophage 
There are 13 families of bacteriophage classified by capsid morphology, 
nucleic acid composition, and other characteristics such as presence of 









The family Tectiviridae (from the Latin tectus meaning covered) 
includes phages possessing an icosahedral protein shell covering an inner 
membrane bilayer containing a linear dsDNA genome. A relatively rare phage 
group, the family currently consists of six isolates that infect gram-negative 
bacteria and six that infect gram-positive bacteria. Gram-negative infecting 
tectiviruses include PRD1 [9] and five closely related phages: PR3 [17], PR4 
[18], PR5 [19], PR772 [20], and L17 [21]. Gram-positive infecting tectiviruses 
include Bam35 [22], AP50 [23], phiNS11 [24], GIL01 [25], and GIL16 [26], and 
Wip1 [1]. 
The majority of bacteriophages have a single central tail fiber that is 
used to penetrate the bacterial cell wall and deliver the viral genome. In 
contrast, tectiviruses are tailless and possess 11 labile vertices capable of 
host binding and DNA delivery [3]. The twelfth vertex is proposed to play a role 
in DNA packaging instead of receptor binding. All sequenced tectiviruses have 
been shown to encode two different lytic enzymes. A proposed model 
suggests that one lysin is a structural component of the virion active against 
the peptidoglycan during genome delivery while the second lysin is 
responsible for host cell lysis and progeny liberation following genome 






PRD1 is the best characterized member of the Tectiviridae family and 
infects a broad range of gram-negative bacteria including Escherichia coli and 
Salmonella enterica [28]. The tailless, icosahedral, inner membrane-containing 
phage possesses a 14,925 bp linear dsDNA genome with covalently linked 
terminal proteins [9]. One-step growth experiments indicated that the latent 
period was about 50 minutes and the burst size is roughly 500 infective 
particles per cell [29]. The PRD1 virion measures 70 nm in diameter and its 
genome shares approximately 98% sequence identity with other gram-
negative infecting tectiviral isolates (PR3, PR4, PR5, and L17). Additionally, 
PRD1 surprisingly shares many striking structural similarities to and a 
proposed common evolutionary lineage with the mammalian adenovirus [30, 
31]. Both viruses share a similar overall architecture, with comparably 
structured capsid lattices and spike complexes at their vertices. 
Through crystallization and mutagenesis studies, PRD1 proteins have 
been fairly well defined. The capsid is stabilized by pentameric glue protein 
P30 and hexameric major coat protein P3. Pentameric vertex protein P31 
occupies each of the twelve vertices and forms the base of the spike complex. 
Two elongated proteins, trimeric spike protein P5 and monomeric receptor 
binding protein P2, form two separate spikes that protrude from P3 [2, 32, 33] 
(Figure 1). The presence of P2 is dependent on P5, while both P2 and P5 are 




Figure 1. Model for the PRD1 spike complex shown from the side 
The PRD1 spike complex is composed of pentameric vertex protein 
P31, trimeric spike protein P5, and monomeric receptor-binding protein 
P2. In this representation of the protein structures, one P5 monomer 
(represented in red, purple, and blue), one P2 monomer (represented in 




The X-ray structure for receptor binding protein P2 resembles an 
elongated sea horse with a distinct B propeller head and tail with a protruding 
proline-rich fin (Figure 1). Receptor binding is likely to occur through the head, 
which is distal to the virion. In one P2 model, the fin-shaped domain is 
proposed to make initial contacts by scanning the host surface in order to 
bring the head domain close to its receptor [4]. In another P2 model, the fin-
shaped domain is suggested to interact with the rest of the spike complex. 
Interaction of protein P2 with the receptor leads to a conformational 
change that results in the dissociation of the metastable spike complex 
proteins from the virion [32]. This is followed by the transformation of the 
spherical internal membrane into a tube-like channel structure for the delivery 
of viral DNA into the host [33, 34]. The genetic material is released into the 
bacterial cell, while the empty phage capsid remains outside [35]. In P2- 
mutants, tube-like channels spontaneously form and release DNA, indicating 
that P2 is also responsible for stabilizing a metastable vertex structure [32]. 
 
2.1.2 Bam35 
Bam35 is a tectivirus that infects gram-positive Bacillus thuringiensis 
[22]. Based on negative-stain electron microscopy and electron cryo-
microscopy with 3-D image reconstruction, the morphology of 73 nm Bam35 
virions was shown to closely resemble that of PRD1 [36, 37] (Figure 2). Similar 
tube-like membrane structures have also been observed for Bam35 upon host 
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binding [36, 37]. While wild-type Bam35 form turbid plaques, an isolate 
designated Bam35c yielded clear plaques and higher propagation titers. The 
14,935 bp linear dsDNA molecule of Bam35c is covalently linked to terminal 
proteins. The Bam35c genome exhibits a similar organization and size as the 
PRD1 genome, but no detectable sequence similarity [37]. On the other hand, 
the Bam35 genome shares high sequence similarity with GIL01 and GIL16, 
tectiviruses that also infect B. thuringiensis [25, 26, 38]. Genomic analysis 
predicted 32 open reading frames (ORFs), all on the positive strand, in a 
tightly packed organization with numerous overlapping ORFs [37]. 
 
 




Bam35 gene products gp27, gp28, and gp29 have been identified as 
candidate proteins for the spike complex. Genomic analysis of the 
organizational location of ORF27 suggested that it is the vertex penton protein 
of the spike complex. By threading Bam35 proteins onto PRD1 X-ray 
structures, it was determined that gp28 is homologous to spike protein P5 and 
that gp29 is homologous to the C-terminal half of receptor binding protein P2 
[36, 37]. In addition, gp28 and gp29 were determined to reside on the surface 
of Bam35 from phage aggregation and neutralization assays using polyclonal 
antibodies [39]. However, competitive binding assays using both recombinant 
and dissociated surface proteins were inconclusive and a Bam35 receptor 
binding protein could not be identified. 
Bam35 was found to rapidly adsorb to the peptidoglycan layer of the 
host with signs of receptor saturation at an MOI of approximately 600 virions 
per one cell [39]. Studies demonstrated that one of the two major sugar 
components of the peptidoglycan, N-acetyl-muramic acid, neutralized the virus 
and thus was proposed to be a receptor for the phage [39]. Upon host 
adsorption, Bam35, like gram-negative infecting PRD1, displayed tube-like 
membrane structures that are hypothesized to deliver the genome into the 
cytosol. Based on electron microscopy, mature virus particles accumulate at 
the center of the infected host at about 40 minutes post infection. Lysis occurs 
at roughly 45 minutes post infection and takes 15 minutes to complete before 




2.1.3 GIL01 and GIL16 
GIL01 and GIL16 are both B. thuringiensis phages with similar 
morphologies to other tectiviruses, characterized by a tailless, icosahedral 
capsid measuring about 60 nm and containing an inner lipid membrane. 
GIL01, an isolate from B. thuringiensis serovar Israelensis, shares 99% 
sequence identity with Bam35, which was isolated from B. thuringiensis 
serovar Alesti. Their genomes differ by only 11 bp and none of the mutations 
significantly alter the genetic organization of either phage, suggesting that 
GIL01 and Bam35 are virtually the same [26]. GIL01 shares 83.6% sequence 
identity with GIL16, an isolate from B. thuringiensis B16. Studies showed that 
GIL01 and GIL16 have slightly different host ranges. Interestingly, GIL01 does 
not infect B. thuringiensis serovar Thuringiensis HER1047, a strain that is 
susceptible to both Bam35 and GIL16 [26]. 
 
2.1.4 AP50 
AP50 is a tectivirus isolated from soil in 1972 that specifically infects B. 
anthracis. TEM analysis revealed a shell composed of two layers displaying 
icosahedral symmetry and SDS-PAGE gels revealed nine major structural 
proteins. Organic solvents such as chloroform and ether inactivated AP50, 
confirming the phospholipid natures of the inner layer [40]. Burst size was 
temperature dependent, with 200 to 300 particles per cell released at 25oC 
and 37oC compared to about 3 to 5 particles per cell at 42oC. Originally 
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thought to contain RNA [23], it has now been determined to possess a 14,398 
kbp linear dsDNA genome encoding 31 putative ORFs [41].  
Wild-type AP50t produces turbid plaques, while the spontaneous 
variant AP50c produces clear plaques. Interestingly, there exist only two 
sequence changes between the two genomes. One mutation is located in the 
non-coding region just upstream of ORF1. The other mutation is located within 
ORF28, which has been designated a highly variable region of the genome 
[41]. While Bam35, GIL01, and GIL16 share 86 to 99% sequence identity, 
AP50c is less closely related to these other gram-positive infecting tectiviruses 
with only ~53% overall percent identity. 
Wild-type AP50t was shown in 1977 to have a very narrow host range, 
infecting only one-third of the 34 B. anthracis strains and none of the 52 B. 
cereus strains tested [42]. Recently, mutant variant AP50c was also shown to 
be highly specific to B. anthracis in an even more extensive host range 
analysis. 111 of the 115 B. anthracis strains and none of the 100 B. cereus 









Wip1 is a recently identified phage isolated from the intestinal tract of 
Eisenia fetida earthworms in 2003 [1]. The earthworms were taken from forest 
floor soil in Stroudsburg, Pennsylvania. Wip1 is a tailless phage with an 
isometric head belonging to the family Tectiviridae (Figure 3) and produces 
tube-like structures after adsorption or chloroform treatment [43]. 
Wip1 exhibits a very narrow host range and is highly specific to the 
notorious pathogen B. anthracis. The current gold standard for identifying 
suspected B. anthracis involves testing for Wγ phage sensitivity [16]. However, 
using Wγ as a diagnostic tool can lead to false positives due to the 
susceptibility of several Bacillus cereus strains to infection by this phage. 
Recent studies have shown that the host range of Wγ is less specific to B. 
anthracis than that of both Wip1 and AP50 [1, 41]. For example, B. cereus 
strain ATCC 4342 is sensitive to infection by Wγ phage but not to infection by 
either Wip1 or AP50. Additionally, the Wγ diagnostic phage yields plaques on 
B. anthracis ∆Sterne only after 5 days, whereas Wip1 plaques can be detected 
after just 12 hours post infection [1]. These advantages suggest that Wip1 may 







Figure 3. Comparison of Wip1 and Wγ  phage morphologies 
A. TEM of Wip1 phage. Scale bar = 25 nm 
Wip1 phage belongs to the family Tectiviridae, characterized by a 
tailless icosahedral protein capsid surrounding an inner lipid membrane. 
The Wip1 vertex to vertex dimension measures about 60 nm. 
B. TEM of Wγ  phage. Scale bar = 50 nm 
Wγ phage belongs to the family Siphoviridae, characterized by an 
icosahedral head with sheathless, non-contractile, long tails. Wγ heads 






Specificity of a bacteriophage host range is often mediated by 
specificity of adsorption.  Receptor-binding proteins on the coat of the phage 
interact very specifically with receptors exposed on the surface of the 
bacterium. Since phage lack independent mobility, adsorption results from 
random phage-cell collisions. It was suggested by Adam and Delbruck that 
adsorption occurs in two stages [44]. In order to efficiently bind to a receptor, 
which is small compared to the overall size of a cell, the phage particle first 
finds the bacterial surface by 3D diffusion involving reversible binding to a 
general recognition molecule. Once on the cell surface, the phage particle 
then diffuses in a 2D fashion until it collides with a specific receptor, which it 
binds to irreversibly. For the two-stage capture model to be advantageous, the 
affinity between the host surface and the phage must be strong enough so 
that the phage remains on the surface yet weak enough so that it can diffuse 
across the surface [45]. While Adam and Delbruck’s theory assumed that all 
collisions lead to binding, more recent studies have observed that that the 
second irreversible binding step is surprisingly inefficient with only a small 
fraction of the collisions leading to actual irreversible binding [46]. 
 
2.2.1 Bacteriophage receptor binding proteins 
The adsorption of phages to the host receptors is mediated by receptor-
binding proteins on the surface of the viral particle. Most receptor-binding 
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ligands are homomultimeric complexes that are involved with functions such 
as cell wall penetration or DNA delivery in addition to host recognition. While 
the domains that attach receptor-binding sites to the virion surface tend to be 
well conserved among the members within a phage group, the receptor-
binding domains are usually encoded in highly variable regions and tend to 
display more sequence diversity. 
The phages p2, bIL170, and TP901-1 are siphoviruses that infect the 
bacterium Lactococcus lactis, used extensively worldwide for manufacturing 
fermented milk products. The crystal structures of the receptor binding 
proteins for these phages have been resolved. Despite lack of sequence 
similarity and differences in host range within L. lactis, the three RBP 
structures are remarkably close [47]. Each is postulated to be a homotrimer 
located at the tip of their long, flexible, non-contractile tail and binds to 
unknown surface saccharides [48]. Additionally, recent X-ray crystallography 
studies showed that p2’s RBP also shares significant structural similarity with 
siphovirus SPP1’s gp22 [49]. This viral protein is hypothesized to form the tip 
of the tail of SPP1, a phage that infects Bacillus subtilis using receptor protein 
YueB.  
Podoviruses bind to cell hosts using stubby tail spikes attached to a 
very short, non-contractile tail. Three to six tail spikes are required for 
infectivity and the receptor-binding site is centrally located on the tail spike. 
The tail spike of podovirus P22 is a stable homotrimer that exhibits both 
binding and hydrolytic cleaving activity against Salmonella cell surface O-
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antigen polysaccharide [50]. Another podovirus K1-5 has evolved to encode 
two different tail spike proteins, one to bind type K1 and the other to bind type 
K5 Escherichia coli strains [51]. Curiously, based on high sequence and 
structural homology, it has been suggested that Podoviridae and Myoviridae 
exchange receptor-binding domains [52]. 
E. coli phage T4 belongs to the family Myoviridae and adsorbs to the 
host surface using both long and short tail fibers. First, the receptor-binding tip 
of the long tail fibers reversibly interacts with lipopolysaccharides or outer 
membrane porin protein C. Upon adsorption with at least three long tail fibers, 
homotrimeric short tail fibers extend and irreversibly bind to the outer core 
region of the lipopolysaccharides. The T4 long tail fibers are a complex of four 
different proteins and possess a receptor-binding tip that is highly homologous 
to the tip of the bacteriophage lambda side tail fibers [53]. 
PX174 is a tailless icosahedral phage with protruding adsorption spikes 
consisting of five G proteins and one H protein. Protein G exhibits a 
significantly higher affinity to E.coli lipopolysaccharide (LPS) than protein H 
towards the same LPS. Spike protein G was also found to form a star-shaped 
pentamer that provides a channel for DNA delivery. Lastly, studies showed 
that protein G recognizes both the polysaccharide and lipid regions of gram-
negative LPS [54]. 
Membrane-containing phages such as PRD1, PM2, and p6 bind to 
receptors using spike proteins. Tectivirus PRD1 has two separate spikes, 
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trimeric spike protein P5 and receptor-binding protein P2, protruding from its 
vertices [2]. P2 is required for both adsorption and stabilization of the labile 
spike complex. Corticovirus PM2 has a pentameric receptor-binding protein P1 
occupying each vertex. The crystal structure of P1 revealed a Ca2+ ion bound 
in a cleft at the tip of the protein that may mark the site of sugar binding [55]. 
Cystovirus p6 binds to its receptor using spike protein P3. 
 
2.2.2 Gram-positive cellular receptors 
The cell wall of gram-positive bacteria differs significantly from that of 
gram-negative bacteria in both composition and structure. Gram-positive 
bacteria typically lack an outer membrane and possess a considerably thicker 
cell wall due to a thick peptidoglycan layer. Peptidoglycan is a heteropolymer 
composed of sugars and amino acids that forms a cross-linked mesh-like layer 
outside the plasma membrane. Gram-positive cells also have cell wall 
glycopolymers attached to the peptidoglycan or cytoplasmic membrane, such 
as teichoic acids, teichuronic acids, arabinogalactans, lipoteichoic acids, 
lipomannans, and lipoarabinomannas. These cell wall glycopolymers 
constitute the bulk of bacterial surface antigens and anchor the crystalline 
surface layer (S-layer) proteins to the cell wall.  
Phage receptors localized on the cell wall of gram-positive bacteria can 
include peptidoglycan, teichoic acids, membrane-anchored proteins, or cell 
wall-linked polysaccharides. N-acetyl-muramic acid, a major component of 
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peptidoglycan, was identified as a component of the B. thuringiensis receptor 
for tectivirus Bam35 [39]. Peptidoglycan was shown to bind to gram-positive 
infecting phages sk1, jj50, and 64 [56]. Teichoic acid has been identified as 
the B. subtilis receptor for bacteriophage SP50, but additional cell wall 
constituents are also believed to be involved in the interaction [57]. 
Bacteriophages p25 and p29 attach to teichoic acid components, while 
lactobacillus phages LL-H and JCL1032 adsorb to lipoteichoic acid elements 
[58].  Teichoic acids are the surface component involved in initial reversible 
binding of phage SPP1 to host cells, followed by irreversible adsorption to the 
ectodomain of B. subtilis protein YueB [59, 60].  
The B. anthracis receptor for Wγ phage was identified as LPXTG 
protein GamR [61]. The protein receptor was discovered based on the 
observation that sortase deficient B. anthracis was not as sensitive as the 
parent strain to Wγ binding and infection. Interestingly, both Wγ sensitive B. 
cereus ATCC 4342 and Wγ resistant B. thuringiensis 97-27 possess very 
similar Gam-R like proteins with 89% and 96% homology, respectively [61]. 
Electron microscopy showed that Wγ phage bound to both strains [61]. These 
observations revealed that GamR is sufficient for virion binding but not for 
DNA delivery into B. thuringiensis 97-27. This suggests that there is a putative 
second receptor necessary for DNA delivery, a cell wall component absent on 




3. Bacillus anthracis 
Bacillus anthracis is a gram-positive, rod-shaped, non-motile, spore-
forming bacterium with a width of 1-1.2 µm and a length of 3-5 µm. It can be 
cultured in ordinary nutrient medium with iron sources under either aerobic or 
anaerobic conditions. It is also one of the few bacteria known to synthesize an 
antigenic capsule consisting of a poly-D-glutamate polypeptide. B. anthracis 
was the first bacterium demonstrated to cause disease. In 1850, Rayer 
described filiform bodies in the blood of animals dying from anthrax. In 1863, 
Davaine showed that anthrax disease could be transmitted from animal to 
animal by injection with infected blood. In 1877, Koch injected cultured B. 
anthracis into animals and generated experimental anthrax disease. A few 
years later, Pasteur successfully attenuated B. anthracis and used the 
attenuated strains to vaccinate sheep against fully virulent strains. 
B. anthracis is both genotypically and phenotypically similar to Bacillus 
cereus, a ubiquitous soil inhabitant, and Bacillus thuringiensis, an insect 
pathogen. The Bacillus family’s distinguishing feature is the production of 
endospores, which are highly resilient, dormant, temporary structures formed 
within the cells. These spores are cryptobiotic with no detectable metabolism. 
B. anthracis spores are particularly durable and can survive environmental 
stresses such as high temperatures, low-nutrient conditions, irradiation, strong 




Analysis of 16S and 23S rRNA has shown that B. anthracis has 
remarkably close relationships with B. cereus and B. thuringiensis. The B. 
anthracis 16S rRNA shares 100% sequence identity with that of B. cereus and 
their 23S rRNA sequences differ by only two nucleotides. B. anthracis is also 
very similar to B. thuringiensis, with only nine nucleotides differing between 
their respective 16S rRNA sequences [62]. Notably, B. anthracis is even more 
similar within itself. In fact, it may be one of the most molecularly homogenous 
bacteria known with shared genetic similarities of over 90% between different 
B. anthracis strains and isolates. 
 
3.1 Anthrax disease 
Bacillus anthracis is the causative agent of anthrax, a severe disease 
that can infect any mammal, including humans. It predominantly infects 
domesticated and wild animals, especially herbivores (including cows, sheep, 
and horses). However, humans can become infected through contact with 
diseased animals or as a result of bioterrorism. In the United States, there are 
1-2 cases per year of naturally acquired anthrax in humans [63]. In September 
and October of 2001, lethal B. anthracis spores were used to deliberately 
contaminate envelopes sent through the mail. This bioterrorism attack led to 
22 infections and five deaths from inhalation anthrax [63]. Today, the Center 
for Disease Control and Prevention continues to classify anthrax as a highest 
priority Category A agent with recognized biowarfare potential. 
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B. anthracis can cause three types of infections: cutaneous, 
gastrointestinal, and inhalational. A cutaneous infection, usually the result of a 
cut or abrasion, is the most common and least dangerous infection type with a 
mortality rate of less than 1% [64]. A gastrointestinal infection, usually the 
result of eating infected meat or drinking contaminated water, is frequently 
seen in carnivores. The inhalation of B. anthracis spores results in bacterial 
germination and colonization of the host’s mediastynal lymph nodes. As the 
capacity of the lymph nodes is exceeded, the bacteria enter the host’s blood 
stream and cause septicemia. The most dangerous of the three types of 
infection, B. anthracis inhalation is almost invariably fatal with a near 100% 
mortality rate if not treated within 24-48 hours of contact [64]. 
The early clinical diagnosis of inhalation anthrax is extremely 
challenging since the initial symptoms mimic that of influenza. Within 2-3 days, 
patients progress from flu-like myalgias, fever, and malaise to dramatically 
more severe symptoms such as dyspnea and hypoxemia, followed by 
hypotension, hemorrhage, and death [65]. B. anthracis is susceptible to the 
antibiotic penicillin, but resistant β-lactamase-positive strains have been 
isolated. Alternative antibiotic drugs include ciproflaxin, erythromycin, 
tetracycline, doxycycline, and chloramphenicol [65]. 
Fully virulent strains of B. anthracis harbor two endogenous plasmids, 
pXO1 and pXO2. pXO1 encodes three toxins that are responsible for the 
majority of pathology associated with B. anthracis while pXO2 codes for the 
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protective capsule. The attenuated Sterne strain has only one plasmid pXO1 
and the avirulent ∆Sterne strain has neither plasmid. 
 
3.2 Bacillus anthracis detection 
The dissemination of B. anthracis spores in a bioterrorist attack 
continues to be a serious concern. A rapid, accurate, and sensitive detection 
method would be a valuable tool for identifying whether B. anthracis is the 
agent of an attack, especially because infection is difficult to diagnose and 
anthrax has a high mortality rate. However, reliable identification of B. 
anthracis is difficult due to its remarkable similarities to B. cereus and B. 
thuringiensis. 
B. anthracis can be identified using basic characterization assays. It is 
sensitive to penicillin, non-motile, and not β-hemolytic on sheep or horse blood 
agar plates. The current standard for B. anthracis identification is lysis by Wγ 
phage. Originally isolated in 1955 by Brown and Cherry, Wγ was found to lyse 
encapsulated smooth forms of B. anthracis but not any B. cereus strains that 
were tested at the time. Later studies have identified two sensitive non-B. 
anthracis strains, B. cereus ATCC 4342 and B. mycoides CDC680, as well as 
two nonsusceptible B. anthracis strains [16]. Additionally, the Wγ lysin PlyG 
was found to lyse B. anthracis is a highly rapid and specific manner and could 
be developed as a tool to quickly detect germinating Wγ sensitive spores [66]. 
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Immunoassays using antibodies against B. anthracis spores, vegetative 
cells, and toxin proteins have also been developed to detect B. anthracis. 
Immunofluorescence systems, ELISA assays, and immunoradiometric assays 
can detect spore surface antigens that are specific to B. anthracis using 
immobilized spores. Some immunoassays, such as serological detection and 
monoclonal antibodies against vegetative cell surface antigens, suffer from 
cross-reactivity [67]. Others, such as sandwich-based antibody arrays and flow 
cytometry to detect fluorescein-labeled antibodies to spores, have detection 
limits. There are also enzyme immunoassays that detect anthrax toxins in the 
blood, but these require the disease to have already progressed to an 
advanced stage [67]. 
B. anthracis can also be detected using DNA-based assays. The United 
States Postal Service had previously installed real-time PCR based anthrax 
screening units at select sorting sites. PCR, real-time PCR, and multiplex PCR 
techniques are based on amplification of B. anthracis specific DNA. Most 
primers are designed to target sequences on either or both of the virulence 
plasmids, pXO1 or pXO2. Studies have also identified a 277 bp region of the 
chromosome that is conserved in 28 B. anthracis strains tested, but could not 
be found in 33 heterologous bacteria strains [67]. However, this target is not 
indicative of virulence and was later found in several B. cereus and B. 
thuringiensis strains. Newer methods of DNA-based B. anthracis detection do 
not require amplification steps such as PCR. Instead, the nucleic acid is 
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detected using a sandwich-hybridization assay with a fluorophore-labeled 
probe [67]. 
 
3.3 Bacillus anthracis surface layer 
The B. anthracis cell wall differs from other gram-positive cell walls in 
that they do not contain teichoic acid, a major cell wall component and popular 
phage receptor in other gram-positive strains, and their surface layers are not 
glycosylated. Furthermore, the cell wall contains carbohydrate residues that 
are specific in composition to B. anthracis and different from that of even 
closely related B. cereus strains [68]. Virulent B. anthracis also forms a poly-D-
glutamate capsule. However, B. anthracis ∆Sterne, the strain mainly used in 
this study, does not harbor the virulent plasmids and thereby does not possess 
a protective capsule. 
Bacterial S-layers are two-dimensional sheets of protein that self-
assemble on the cell surface. In B. anthracis ∆Sterne, S-layers are the 
outermost interaction zone with their respective environment (Figure 4). The 
main S-layer proteins of B. anthracis are Sap and EA1, which are encoded by 
the clustered genes sap and eag, respectively [69]. The gene csaB lies 
adjacent to this operon, is responsible for the pyruvylation of the secondary 
cell wall carbohydrates that S-layer proteins are anchored to, and is required 




Figure 4. Schematic of the B. anthracis ΔSterne cell wall 
 The cell wall of gram-positive B. anthracis ΔSterne has a thick 
peptidoglycan layer composed of cross-linked sugars and amino acids. Major 
components associated with the cytoplasmic membrane and peptidoglycan 
include membrane lipoteichoic acids, cell wall proteins, and cell wall 
polysaccharides. These associated glycopolymers anchor the crystalline 
surface layer Sap and EA1 proteins to the cell wall. The B. anthracis cell wall 
differs from other Bacillus strains in that it lacks teichoic acids and S-layer 




In B. anthracis, Sap and EA1 are sequentially produced under growth 
phase control. Studies have suggested that an exponential phase Sap layer is 
subsequently replaced by a stationary phase EA1 layer [71]. In part, this 
regulation is due to recognition of the sap promoter by SigA, the housekeeping 
sigma factor for RNA polymerase, and recognition of the eag promoter by 
SigH, a transition state regulator that quadruples in concentration at the onset 
of stationary phase [71]. This regulatory mechanism is highly flexible, as 
shown by the observation that Sap is readily expressed if stationary phase 
cells are resuspended in fresh medium. 
 
4.  Objectives of the Study 
The goal of this study was to develop a better understanding of Wip1’s 
highly specific tropism for B. anthracis by studying the spike complex. We 
started by imaging the morphological changes of Wip1 phage upon 
adsorption, expanding its host range analysis with adsorption studies, and 
sequencing its viral genome. Based on genomic analysis comparing the Wip1 
genome with that of other gram-positive infecting tectiviruses, candidate gene 
products for the Wip1 spike complex were predicted and used to identify a 






B.  MATERIALS AND METHODS 
 
1. Bacterial strains and phages 
The majority of bacterial strains in the present study have been 
previously described [1, 43, 66]. All bacterial strains were grown in brain heart 
infusion (BHI; Remel) broth or agar plates at 30oC according to standard 
protocols. The bacteriophage Wip1 was isolated from the intestinal tract of 
Eisenia fetida worms from Pennsylvania, USA. Phage propagation was 
performed on the B. anthracis ∆Sterne strain. 
 
2. Phage propagation 
High titer phage stocks were obtained by infecting stationary cell 
cultures (100 µl) with 100 µl of a series of diluted (1:100 to 1:1000) Wip1 
phage stocks. The phage-bacterium mixtures were incubated in a 37oC 
waterbath for 15 min and then plated with molten top agar (0.8%) onto BHI 
plates and incubated overnight at 30oC. When the viral plaques reached near 
confluency, the soft agar overlays were collected in conical tubes, incubated 
with 2 ml 10 mM K phosphate per plate for 15 min at room temperature, and 
centrifuged at 4,000 rpm for 20 min at 4oC. The resulting supernatants were 




3. Phage purification scheme 
 High titer stocks of 1E9 – 1E10 PFU/ml Wip1 phage were produced and 
filtered. Thee stocks were precipitated using PEG8000 and then concentrated 
10X by centrifugation (Sorvall GS-3; 8,000 rpm; 30 min; 4oC). Phage pellets 
were resuspended in 10 mM KPhosphate. Step gradients of CsCl layers were 
overlaid with concentrated phage and centrifuged (Ti40 rotor; 22,000 rpm; 3 h; 
4oC). Bands were extracted using both needle puncture and fraction removal 
by pipette. Alternately, concentrated phage stocks were also overlaid on 
continuous sucrose gradients of 20 – 70% that were centrifuged (Ti40 rotor; 
22,000 rpm; 24 h; 4oC). Bands were extracted by pipette removal of fractions. 
The gradient fractions containing the phage bands were dialyzed against 10 
mM K Phosphate at 4oC and then titered on B. anthracis ∆Sterne to test for 
activity. 
 
4. Transmission electron microscopy 
Wip1 phage were incubated with overnight cultures of B. anthracis 
∆Sterne at a MOI of 10 for 5 min at 37oC. After incubation, the mixtures were 
transferred to a new microfuge tube with solidified agar on the bottom to act as 
a cushion during the subsequent centrifugation at 6000 rpm for 3 min. 
Supernatant was removed and the pellet was resuspended in 1x fixative. The 
TEM analyses were then performed at The Rockefeller University Bio-Imaging 
Resource Center as previously described [43]. 
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5. Chloroform sensitivity assay 
Wip1 phage samples (2 ml) were incubated with and without various 
volumes of chloroform (up to 80 µl) in capped glass tubes with gentle mixing at 
room temperature for 15 min. The mixtures were then titered on B. anthracis 
∆Sterne. W2 phage with and without chloroform plated on B. cereus ATCC 
4342 was used as a control. 
 
6. Phage adsorption assay 
Various bacterial strains were grown to stationary phase (approximately 
2 x 108 CFU/ml) and 100 µl of bacteria was mixed with 100 µl of Wip1 at 2 x 
107 PFU/ml. The phage-bacterium mixtures were incubated in a 37oC 
waterbath for 20 min and then pelleted at 7000 rpm for 3 min. The resulting 
supernatants were subsequently spin-filtered (Millipore; 0.22 µm) and titered 
on plates of B. anthracis ∆Sterne. 
 
7. DNA manipulation and sequencing 
To obtain Wip1 DNA, Wip1 phage stock was lysed using NaOH and 
then neutralized with Tris buffer and water. Tsp5091-digested restriction 
fragments of mixed population were ligated to linkers, PCR amplified, and 
inserted into TOPO vectors. After transforming these mixed plasmids into a 
library of One Shot TOPO competent cells, uniform plasmid preparations were 
	  
 31 
extracted and sequenced. Sequences derived from these transformed cells 
were aligned to form a contiguous sequence using DNAStar Lasergene 
Seqman Pro software. The final contig exhibited 11X average coverage and 
was confirmed by sequencing PCR products generated directly from Wip1 
phage DNA. 
 
8. DNA purification 
 In order to extract purified DNA from Wip1, high titer phage stocks were 
first concentrated using direct centrifugation (UC 35K rotor; 30,000 rpm; 6 h; 
4oC). The pellet was resuspended in 1/100 original volume of 10 mM K 
Phosphate buffer. To remove viral coat proteins, 1/5 resuspension volume of 
10% SDS and 1/5 resuspension volume of 10 mg/ml protease K were added 
and the reaction was incubated at 55oC for 1.5 h. Organic solvents were then 
used to disrupt the lipid membranes and separate phage DNA through 5X 
phenol extractions followed by 2X chloroform extractions. The DNA in these 
solutions was ethanol precipitated, washed in 75% ethanol, and finally 
resuspended in 1/1000 original volume of ddH2O. The extracted DNA was 






9. DNA-terminal protein analysis 
 To test for the presence of covalently linked terminal proteins, the 
purified DNA was subjected to further protease K treatment followed by 
multiple phenol and chloroform extractions, ethanol precipitation and washes, 
and resuspension in ddH2O. The conditions for these steps are outlined 
above in the DNA purification methods. DNA samples with and without this 
second round of protease K treatment were analyzed using gel 
electrophoresis. 
 
10. Lysogen induction assay 
 A lysogenic strain of B. anthracis ∆Sterne harboring a Wip1 prophage 
was tested for induction by UV irradiation. Overnight cultures of the lysogen 
were inoculated in BHI and grown to exponential phase for 3 h shaking at 
30oC. These cells were pelleted and resuspended in 5 ml of 10 mM MgSO4 
and transferred into an uncovered dish. This dish of cells was irradiated with a 
254 nm lamp from above at a distance of about 10 cm for 10 seconds. The 
cells were then incubated at 37oC shaking at 200 rpm for 15 min. Once again, 
they were pelleted and resuspended in liquid BHI media. Phage induction was 
allowed to proceed for 90 min at 37oC shaking at 200 rpm before culture 
supernatants were recovered and filtered (0.45 µm). Filtered supernatants 
from both irradiated and non-irradiated cells were titered on B. anthracis 
∆Sterne in BHI plates. 
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11. Cloning of his-tagged Wip1 ORFs 22, 23, and 24 
Standard molecular-cloning techniques were performed as described 
by Sambrook and Russel. The PCR products containing the coding sequences 
for the Wip1 gene products 22, 23, and 24 were separately amplified using 
specific primers. Each DNA fragment was inserted into a modified CDFDuet-1 
plasmid between the SalI-NotI sites preceded by a T7lac promoter and 
ribosome binding site as well as two sets of His-tag sequences. Clones were 
confirmed by sequencing using primers that flank the insert. 
 
12. Purification of his-tagged Wip1 p22, p23, and p24 
Overnight cultures of E. coli DH5alpha cells carrying the cloned 
constructs were diluted 1:100 and grown in LB medium with spectinomycin (20 
µg/ml) for 4 h while shaking at 37oC. After being moved to 16oC, the cultures 
were induced with isopropyl-b-D-thiogalactopyranoside (IPTG) at a final 
concentration of 0.25 mM and shaken for an additional 18 h. Bacterial pellets 
were collected by centrifugation (Sorvall SLC-6000 rotor; 7200 rpm; 30 min; 
4oC) and resuspended in a cold buffer (50 mM Tris, pH 8.0 + 200 mM NaCl + 
5 mM imidazole) at 1/100 of the original culture volume. Bacterial lysis was 
conducted by multiple passages through a French pressure cell (at ~105 MPa) 
at 4oC. The cell debris was removed by centrifugation (Sorvall SS-34 rotor; 
8,000 rpm; 20 min; 4oC) followed by filtration (Nalgene; 0.45 µm).  
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The following purification steps were conducted at room temperature 
using buffers kept at 4oC. 25 ml columns were loaded with 1.25 ml bed volume 
of Ni-NTA agarose (Qiagen) and equilibrated with 2x column volumes of buffer 
(50 mM Tris, pH 8.0 + 200 mM NaCl + 5 mM imidazole). The cell lysate from 
induced cultures was passed through the columns 2x using gravity flow. The 
Ni-NTA agarose was then washed with 1x column volume of wash buffer A (50 
mM Tris, pH 8.0 + 500 mM NaCl + 30 mM imidazole) and 0.5x column volume 
of wash buffer B (50 mM Tris, pH 8.0 + 500 mM NaCl + 60 mM imidazole). 
Finally, the eluate was collected by passing 5x bed volume of elution buffer 
(50 mM Tris, pH 8.0 + 500 mM NaCl + 250 mM imidazole) through the column. 
In preparation for the next step of the purification process, the eluted 
proteins were dialyzed against buffer A (20 mM phosphate buffer; pH 7.4) at 
4oC. Ion exchange chromatography was then conducted using a 5 ml HiTrap 
Q HF column at a linear gradient from 100% Buffer A targeting 50% Buffer B 
(20 mM phosphate buffer + 1 M NaCl; pH 7.4). Fractions containing the 
purified proteins of interest were collected, analyzed with SDS-PAGE, pooled, 







13. Cloning and purification of co-expressed his-p23 and p24 
The cloning and purification schematic of his-p23 and p24 is exactly the 
same as described for the individual recombinant proteins. The only difference 
is that the PCR insert at the multiple cloning site began with the start codon for 
ORF23 and ended with the last codon for ORF24. There are only 12 bp 
separating the two ORFs. It should be noted that ORF24 was not cloned into a 
separate site with its own promoter and tag. 
 
14. Inclusion body protein extraction 
 Overnight cultures of the clones carrying the recombinant constructs 
were inoculated into BHI medium and induced with IPTG (0.5 mM final 
concentration). Recombinant protein expression was allowed to proceed for 4 
h shaking at 37oC before pellets were collected via centrifugation (Sorvall 
SLC-6000 rotor; 7200 rpm; 30 min; 4oC). The cell pellets were completely 
resuspended in room temperature BugBuster reagent, using 5 ml per gram of 
wet pellet weight. The cell suspensions were incubated for 20 min rotating at 
room temperature and centrifuged (Sorvall SS-34; 16,000 rpm; 20 min; 4oC). 
The supernatants with soluble protein were saved for SDS-PAGE analysis. 
 The pelleted inclusion bodies were then resuspended in the same 
volume of BugBuster reagent. Lysozyme was added at 200 µg/ml final 
concentration and the mixture was vortexed and incubated at room 
temperature for 5 min. 6 volumes of 1:10 diluted BugBuster reagent was 
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added to the suspension before another vortex for 1 min. The suspension was 
centrifuged (Sorvall SS-34; 16,000 rpm; 15 min; 4oC) and washed 3X in 1:10 
diluted BugBuster. The final pelleted inclusion body fraction was resuspended 
in PBS and analyzed using SDS-PAGE along with the soluble protein 
fractions. 
 
15. Inhibition of phage infection 
Overnight cultures of B. anthracis ∆Sterne (12 µl) were mixed with 
molten soft agar (0.8%; 400 µl) and overlayed onto BHI agar plates measuring 
35 x 10 mm. After letting the bacterial soft agar sit for 15 min, various dilutions 
of the purified his-tagged phage protein stocks (PBS dilutions; 100 µl) were 
evenly overlaid on top. The protein overlay was incubated atop the bacterial 
agar for 15 min before a final overlay of Wip1 phage (~100 PFU) was evenly 
added. Resulting plaques were counted at 48 hrs post infection. All steps were 
conducted at room temperature. 
 
16. Inhibition of phage adsorption using polyclonal antisera against 
his-p23 
To generate polyclonal antisera against his-tagged Wip1 p23, 500 µg of 
the purified protein was run on an SDS-PAGE gel and excised bands were 
used as antigen to immunize 2 New Zealand white rabbits. Pre-immune serum 
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was collected before the first immunization in complete Freund’s adjuvant and 
for the second, third, and fourth immunizations in incomplete Freund’s 
adjuvant. Immunizations and production bleeds were collected at 3-week 
intervals for a total of 21 weeks. 
The antisera were then tested for ability to inhibit Wip1 phage binding 
activity. Various dilutions of serum (in BHI media) were mixed with Wip1 
phage stock (~800 PFU) and incubated in a 37ºC waterbath for 30 min. After 
adding 100 µl of overnight cultures of B. anthracis ∆Sterne, the serum-phage-
bacterium mixtures were incubated at room temperature for 30 min. Bacterial 
pellets were collected via centrifugation at 12,500 rpm for 30 seconds, 
washed, and resuspended in 10 mM K Phosphate buffer. Bacteria-bound 
phage were plated onto BHI and proceeded to form plaques overnight. The 
inhibition rate was measured as the percentage reduction of Wip1 PFUs as 
compared to a no-serum, PBS control. 
 
17. Indirect immunofluorescence microscopy 
The following protocol is a modified version of one previously described 
[72]. Overnight cultures of various bacterial strains were inoculated at a 1:100 
dilution in BHI media and grown to mid-exponential phase (unless otherwise 
noted) by shaking for 3 h at 30oC. The cell cultures were then pelleted by 
centrifugation (Eppendorf 5810 R; 4,000 rpm; 5 min; 4C), washed, and then 
resuspended in PBS. To fix the cells, paraformaldehyde and NaPO4, pH 7.4 
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were added to the suspension at final concentrations of 2.6% and 30 mM, 
respectively. The cells were incubated for 15 min at room temperature, 
followed by 30 min on ice, washed with PBS, and then attached to polylysine-
coated glass cover slips. The fixed cells attached onto glass were then 
washed with PBS and blocked with PBS containing 1% BSA for 15 min. The 
cells subsequently underwent a series of 3 labeling steps: first with purified 
his-tagged Wip1 protein, then with anti-His mouse antibodies, and finally with 
anti-mouse rhodamine dye and 4’,6-diamidino-2-phenylindole (DAPI) strain. 
Each labeling step consisted of incubating the cells with the labeling mixture 
for 45 min in a moist chamber and was followed by thorough washes with 
PBS. To reduce bleaching, the slides were mounted with 50% glycerol and 
0.1% p-phenylenediamine in PBS pH 8.0. Images were captured using a 
Delta-Vision image restoration microscope (Applied Precision/ Olympus) 
equipped with CoolSnap QE cooled CCD camera (Photometrics). An Olympus 
100x oil immersion objective was used in conjunction with a 1.5x optovar. 
 
18. Pull-down assay using his-p23 and Ni-NTA 
Overnight cultures of B. anthracis ∆Sterne and B. cereus ATCC 4342 
were inoculated in BHI media and grown to exponential phase by shaking for 
3 h at 30oC. After being pelleted and washed in PBS, the cells were then 
resuspended in PBS + 30% raffinose. PlyG lysin was added and the mixture 
was incubated for 1 h at 37oC. The intact cell protoplasms were pelleted and 
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the dissociated cell wall fragments remaining in the supernatant were removed 
for use in the pull down assay. The following steps using Ni-NTA agarose 
were conducted with the same buffers and conditions as the Ni-NTA 
purification scheme previously outlined in this study. The Ni-NTA columns 
were equilibrated and loaded first with purified his-tagged viral ligand p23 and 
then with the cell wall supernatant. Multiple subsequent washes and elution 
fractions were collected, concentrated with TCA precipitation, and evaluated 
on SDS-PAGE gels. 
 
19. Phage adsorption assay using protease treated cells 
Overnight cultures of stationary phase B. anthracis ∆Sterne and B. 
cereus ATCC 4342 were pelleted, washed, and resuspended in either PBS, 
PBS + pronase (1 mg/ml), or PBS + protease (1 mg/ml). After incubating the 
cells for 1 h at 37oC, they were pelleted, washed, and resuspended in PBS. 
Treated and untreated cells were then incubated with Wip1 phage for either 5 
or 20 min at 37oC before spin filtration. The unbound phages in the filtrate 
were titered using ∆Sterne and plated on BHI agar. 
 
20. Bacterial surface carbohydrate extraction 
The following procedure was conducted over the course of 
approximately one week with pellets frozen overnight each day. Overnight 
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cultures of B. anthracis ∆Sterne and B. cereus ATCC 4342 were inoculated in 
BHI media and grown for 6 h at 30oC. This culture was then used to inoculate 
multiple liters of BHI media grown to stationary phase by shaking overnight at 
30oC. Cells were collected via centrifugation (Sorvall SLC-6000 rotor; 7200 
rpm; 30 min; 4oC) and washed multiple times with PBS before a final pellet 
was frozen at -80oC. Frozen cells were resuspended in cold ddH2O using 1 ml 
of water per 0.5 g wet weight of pellet. After lysis by passing 3X through a 
French Pressure Cell at 15,000 – 20,000 psi, cell walls were separated via 
centrifugation (Sorvall SS-34 rotor; 15,000 rpm; 30 min; 4oC). These cell wall 
pellets were washed for a minimum of 6X with PBS ensuring vigorous 
resuspension between each wash. The final pellet was resuspended again in 
cold ddH2O using approximately 10 ml per 1.0 g wet weight of pellet.  
To dissociate cell wall-anchored proteins, this suspension was slowly 
added to a boiling solution of 2% SDS for roughly 15 min before cooling down 
at room temperature for 30 min. Boiled cell walls were then sedimented via 
centrifugation (Sorvall GS-3 rotor; 8,000 rpm; 40 min; 4oC) and washed at 
least 4X with ddH2O to remove traces of SDS. Cell wall associated 
carbohydrates were then separated using a hydrofluoric acid treatment. Cell 
wall pellets resuspended in ddH2O were frozen in a vacuum tube using a dry 
ice and ethanol bath before overnight lyophilization. For each 100 mg of 
lyophilized cell wall product, 20 ml of 48-51% hydrofluoric acid was added 
while stirring. This solution was first incubated at room temperature for 1 h 
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without a cover and subsequently incubated at 4oC overnight with a secure 
cover. 
The next morning, the solution was centrifuged (Sorvall SS-34 rotor; 
14,000 rpm; 10 min; 4oC) and the peptidoglycan-associated carbohydrates in 
the supernatant were saved in a polypropylene container. Each 1 ml of 
supernatant was treated with 5 ml of absolute ethanol and incubated at 4oC for 
1 h. This solution was centrifuged (Sorvall GS-3; 8,500 rpm; 30 min; 4oC) and 
the resulting pellet was then washed 3X with absolute ethanol (Sorvall SS-34; 
16,000 rpm; 30 min; 4oC). The final polysaccharide pellet was left uncovered 
at room temperature for 30 min to allow ethanol to evaporate before being 
frozen at -20oC. Later, the precipitate was dissolved in cold ddH2O, 
lyophilized, and stored at 4oC. 
 
21. Surface carbohydrate inhibition assay 
 The lyopholized surface polysaccharides from hydrofluoric acid 
treatment were resuspended in ddH2O at a final concentration of 8 mg/ml. 
Various titers of Wip1 phage stock (100 µl) were incubated with aliquots of the 
extracted surface carbohydrates (100 µl) for 40 min in a 37oC waterbath. 
Carbohydrate to phage ratios ranged from 0.8 mg carbohydrate sample per 
100 PFU Wip1 to 0.8 mg carbohydrate sample per 100,000 PFU Wip1. After 






1. Wip1 morphology 
Wip1 phage produced clear plaques on B. anthracis Sterne and 
∆Sterne strains. Samples of the viral particles with and without the bacterium 
B. anthracis ∆Sterne were analyzed by transmission electron microscopy. 
Wip1 phage alone appeared as tailless, bilayer, icosahedral particles with a 
vertex to vertex diameter of approximately 60 nm, similar in morphology to 
other tectiviral phages. 
Treatment with chloroform inhibited Wip1 activity, which is consistent 
with Wip1 possessing an inner lipid membrane (Figure 5). A control phage 
without a lipid membrane, W2, was not affected by chloroform treatment in its 
infectivity against host strain B. cereus ATCC 4342. Interestingly, chloroform 
treatment produced a 1.0 x 10-4 PFU/ml reduction in Wip1 infectivity but did 
not completely eliminate activity. In contrast, tectiviruses Bam35 and GIL16 
are completely disrupted by chloroform treatment. However, treatment with 
organic solvents, such as chloroform and ether, for 30 minutes also inactivated 
AP50 to a survival of about 1 x 10-4 PFU/ml [40]. It is suspected that this 






Figure 5. Effect of chloroform treatment on Wip1 and W2 infectivity 
Wip1 and W2 were tested for chloroform sensitivity by incubating phage 
with chloroform for 15 minutes before titering on the respective host 
strain. Wip1 exhibited inactivation while W2, which does not contain a 
lipid membrane, did not. 
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Upon incubation with its host B. anthracis ∆Sterne, Wip1 displayed a 
tube-like structure (Figure 6) that has been described in other tectiviruses 
including Bam35 and PRD1 [3, 22, 36]. In PRD1, interaction of protein P2 with 
the host receptor leads to a conformational change that results in the 
dissociation of the spike complex proteins from the virion [32]. This is followed 
by the transformation of the spherical internal membrane into a tubular 
channel structure for the delivery of viral DNA into the host [34, 74]. In some 
cases, the Wip1 tube-like structures were seen to interact in a conventional 
manner with the bacterial cell surface. However, interestingly, TEM images 
captured several Wip1 phages with tube-like structures facing away from the 
bacterial surface (Figure 6: B,C) instead of directly towards the host, a 
phenomenon not observed in other tectiviruses [75]. This could indicate that 
the labile vertex undergoing tubular transformation may not be the same as 
the vertex that initially binds the receptor. This could also be explained by 












Figure 6. TEM images of Wip1 upon adsorption 
Wip1 was incubated with B. anthracis ∆Sterne for 5 minutes at a MOI of 
10 before being fixed for TEM imaging. Scale bar = 0.1 µ 
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2. Wip1 stability 
 Wip1 was tested for stability over time in different buffer conditions, 
such as BHI (brain heart infusion), PBS (phosphate buffered saline), PM2 
phage buffer (20 mM Tris-HCl, pH 7.2), SM phage buffer (50 mM Tris-Cl, pH 
7.0; 0.1 M NaCl; 8 mM MgSO4; 5 mM CaCl2), and Bam35 phage KP buffer 
(10 mM K Phosphate, pH 7.2). Results across the various buffers were similar, 
with Wip1 retaining infectivity fairly well in each buffer. Bam35 phage 
potassium phosphate (KP) buffer was selected as the standard Wip1 buffer in 
all subsequent experiments for consistency. 
High titer stocks of filtered Wip1 phage stored in 10 mM K Phosphate 
buffer at 4oC exhibited higher stability over time than did Bam35 stored in the 
same buffer. While Bam35 experienced a decay of infectivity of about 1 log 
per 12 days [37], Wip1 experienced an approximately 1 log decrease in 
infectivity per 60 days. Remarkably, Wip1 also retained its infectivity after 
exposure to UV for up to 5 minutes and vigorous vortexing for up to 2 minutes 
(data not shown). Experiments in this study that required serial dilutions of 
Wip1 phage utilized vortexing for up to 30 seconds as a technique for rapid 







Figure 7. Wip1 stability in various buffers 
Wip1 was tested for infectivity over time in storage at 4oC in various 
buffers: BHI (brain heart infusion broth), PBS (137 mM NaCl; 2.7 mM 
KCl; 4.3 mM Na2HPO4; 1.47 mM KH2PO4; pH 7.4), PM2 phage buffer 
(20 mM Tris-HCl, pH 7.2), SM phage buffer (50 mM Tris-Cl, pH 7.0; 0.1 
M NaCl; 8 mM MgSO4; 5 mM CaCl2), and KP buffer (10 mM K 





Wip1 lost infectivity during phage purification schemes that involved 
either CsCl or sucrose gradients. Stepwise gradients using CsCl produced two 
major bands, one at 1.3 g/ml and the second between 1.2 and 1.25 g/ml 
(Figure 8). Continuous gradients using 20 – 70% sucrose normally produced 
one major band between 60 – 70%, although one particular sucrose gradient 
spin produced multiple bands (Figure 8). All bands were extracted by either 
needle puncture or by fractionation and tested for phage activity. 
Unfortunately, the particles recovered from the bands exhibited infectivity of 
only 1 x 102 PFU/ml, a significant decrease from the original 1 x 1010 PFU/ml 
stock used for the gradients. No infectivity was detected in any other fractions. 
Similarly, CsCl gradients were also found to significantly decrease 
Bam35 infectivity [37]. The high ionic strength environment was thought to 
cause coat protein dissociation from the virion. Due to the observed 
inactivation of phage, CsCl and sucrose gradient purification schemes were 
abandoned. All subsequent experiments performed with Wip1 phage used 










Figure 8. Bands resulting from CsCl and sucrose gradients with Wip1 
A. CsCl gradients 
B. Sucrose gradients 
CsCl and sucrose gradient purification of Wip1 phage produced visible 
bands that were extracted. However, particles recovered from the 
bands exhibited a 1 x 10-8 PFU/ml loss of infectivity from the original 
titer. None of the other gradient fractions exhibited phage activity 
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3.  Wip1 adsorption is specific to B. anthracis 
Previous studies determined that Wip1 infectivity is more specific to B. 
anthracis than is the standard diagnostic tool Wγ phage [1]. This host range 
study was expanded to include both infectivity and adsorption of Wip1 virions 
to various strains. Infectivity was measured by titering phage directly against 
test strains on agar plates. Adsorption was assayed by incubating Wip1 with 
test strains for 20 minutes, separating bacterium-bound phage via 
centrifugation and filtration, and then titering the unbound phage in the 
supernatant on B. anthracis ∆Sterne. The adsorption rate was calculated as 
the percentage of bound Wip1 phage (# total phage – # unbound phage) out 
of the total phage count (as determined by a buffer only control). 
The narrow range of adsorption showed that Wip1 binding exhibited a 
high specificity to B. anthracis that corresponded to its narrow infectivity host 
range (Table 2). Wip1 exhibits high infectivity of 6 x 109 and a 100% 
adsorption rate on host strain B. anthracis ∆Sterne. Similarly, Wip1 exhibits 
infectivity of 3 x 107 and a 94% adsorption rate on B. cereus CDC32805. On 
the other hand, Wip1 does not infect B. cereus ATCC 4342 and 
correspondingly does not adsorb to it. These observations further support the 






Table 2. Wip1 infectivity and adsorption range 
Various bacterial strains were tested for Wip1 infectivity and adsorption. 
The lower limit of detection of infectivity is indicated by “< 10”, while the 
lower limit of detection of adsorption is indicated by “< 5”. The Wip1 






 Wip1 adsorption kinetics was studied by assaying the amount of bound 
phage at various time points. As expected, B. cereus ATCC 4342 bound < 5% 
of Wip1 phage, the lower limit of detection of adsorption. On the other hand, 
stationary phase B. anthracis ∆Sterne bound approximately 80% of virus 
particles during the first minute after phage adsorption and had adsorbed 99% 
after 10 minutes (Figure 9). Bam35 experienced similar adsorption kinetics 
with various B. thuringiensis strains. Strain 4I1 bound ~65% of phage in the 
first minute and ~90% after 10 minutes, while strain HER1410 was found to 
bind ~80% of virions in the first 20 seconds and 96% by 5 minutes [39]. Both 











Figure 9. Wip1 adsorption kinetics 
Wip1 was incubated with either B. anthracis ∆Sterne or B. cereus 
ATCC 4342 for various lengths of time. Unbound phages were 
separated via centrifugation and filtration before being titered on 
∆Sterne. The adsorption rate was calculated as the percentage of 
bound phage (total – unbound) out of total phage. Bars represent 
standard errors of 6 experiments at MOIs from 1e-4 to 10. 
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4. Wip1 DNA analysis 
 DNA was isolated from Wip1 phage by first denaturing the viral coat 
proteins using protease K and SDS. After the denatured proteins were 
removed by extraction with organic solvents phenol and chloroform, the DNA 
was precipitated with ethanol and stored in buffer. 
Based on DNA analysis, the Wip1 genome was determined to be a 
linear molecule of dsDNA. Pulse field gel electrophoresis of purified Wip1 DNA 
revealed a strong band estimated to be approximately 15 kbp (Figure 10). This 
length is consistent with that of other tectiviruses, including Bam35c (14,935 
kb) and PRD1 (14,925 kb). The double stranded nature of the DNA was 
indicated by both band migration according to its sequenced length and 
ethidium bromide (EtBr) staining. EtBr is a fluorescent tag that preferentially  
intercalates double stranded structures of nucleic acids. Although it is possible 
for EtBr to stain ssDNA, the signal is very weak. Serially diluted samples of 











Figure 10. PFGE of extracted Wip1 DNA 
Pulse field gel electrophoresis migration of extracted Wip1 DNA was 




The extracted genomic DNA was tested for the presence of covalently 
linked terminal proteins. DNA isolated from PRD1 and Bam35 was attached to 
terminal proteins and could not properly enter an agarose gel, but protease 
treatment allowed proper DNA migration [37]. In contrast, we observed similar 
migration between Wip1 DNA treated with and without protease (Figure 11). 
This observation suggested that, unlike the PRD1 and Bam35 genomes, Wip1 
DNA is not associated with proteins. 
However, the DNA extraction method was later re-evaluated for 
potential removal of DNA-associated proteins even before the protease 
treatment assay was conducted. It was originally thought that the Wip1 inner 
membrane would protect its DNA from exposure to the protease step used to 
remove coat proteins before phenol inactivation. But dissociation of the PRD1 
spike complex protein P2 has been shown to promote tubular transformation 
and DNA delivery [3]. It is possible that protease K digestion of the viral capsid 
also leads to DNA release, which would expose the genome to protease 
during the original DNA extraction. Due to this possibility, the protease 







Figure 11. Gel of Wip1 DNA with and without protease treatment 
Extracted Wip1 DNA was treated with and without protease K before 
subsequent purification using phenol/ chloroform extractions and 
ethanol precipitation. Migration of the resulting DNA samples was 






5. Wip1 genome analysis 
Linker-mediated PCR amplification and shot-gun based sequencing 
determined the Wip1 genome length to measure 14,319 bp. The closest 
reported virus in the NCBI database in terms of genome size is AP50 with 
14,398 bp. The average guanine-cytosine (GC) content of Wip1 is 36.9%, 
which is lower than that reported of other tectiviruses such as Bam35c (39.7%) 
and PRD1 (48.1%) [37]. We noted that the Wip1 genome GC content at both 
extremities is lower than the percentage observed in the central section of the 
genome. The first and last genes, ORF1 and ORF27, have GC contents of 
29.5% and 29.7%, respectively. In contrast, ORF18 and OPF19, located at the 
genome center, have GC contents of 43.1% and 44.8%, respectively (Table 
3). 
Detailed analysis of the Wip1 sequence revealed the existence of 27 
putative open reading frames (ORFs), as listed in Table 3. The tightly 
organized genome with few noncoding regions, small intergenic spaces, and 
some overlapping ORFs is characteristic of its family Tectiviridae. Many of the 
predicted genes are remarkably short, also similar to other tectiviruses. PRD1 
has been shown to code for a protein as short as 42 residues (protein P20). In 
comparison, the shortest predicted Wip1 genes are ORF1 and ORF11, each 





Table 3. Comparative analysis of predicted Wip1 ORFs with AP50, 






Figure 12. Map of Wip1 genome and tectiviral genome analysis 
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Based on BLAST analysis and tectiviral genome organization, 14 out of 
27 ORFs were designated putative functions. Wip1 encodes two different 
lysins, ORF20 and ORF26, which are predicted to be a muramidase and an L-
alanyl-D-glutamate peptidase, respectively. Interestingly, the N-terminal half of 
ORF20 contains a conserved FlgJ domain. FlgJ is a Salmonella enterica 
flagellar protein with peptidoglycan hydrolase activity that digests through the 
peptidoglycan layer to facilitate rod penetration. BLAST analysis did not 
identify any conserved domains for ORF26, but did indicate homology to 
peptidases from B. cereus and Listeria. 
While Wip1 exhibits some sequence similarities to gram-positive 
infecting tectiviruses Bam35c and Gil16c, it is most closely related to AP50. 
Wip1 and AP50 both exhibit very narrow host ranges highly specific to B. 
anthracis [41]. The genome of Wip1 from ORF4 through ORF26 is strikingly 
similar to the section of AP50 from ORF9 through ORF31 in ORF size, 
sequence, and organization (Figure 12). Among the 27 total putative Wip1 
ORFs, 20 share sequence identity of at least 50% to other tectiviral proteins 
and 15 share high sequence identity of at least 75% to AP50 proteins.  
The most remarkable distinction of the Wip1 genome is the placement 
of the putative DNA polymerase, ORF27, at the 3’ end of the genome on the 
negative strand. All other tectiviral DNA polymerases are encoded in the first 
5000 base pairs of their genomes on the positive strand. In fact, Wip1 ORF27 
is the only predicted gene found on the negative strand of any gram-positive 
infecting tectivirus. While the putative ExoII, S/TLx2h, Kx2h, and ExoIII motifs 
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of the 3’-5’ exonuclease domain were identified, the unusual sequence lacked 
some of the more highly conserved motifs such as motif C or a clear ExoI 
motif. Furthermore, the unusual Wip1 ORF27 gene product does not share 
any significant homology with any other proteins in the NCBI database. 
Another notable section of the genome involves the regulatory elements 
located at the beginning of the sequence. Wip1 ORF3 was predicted to be a 
LexA-type repressor based on BLAST homology. Despite its lack of sequence 
similarity to tectiviral sequences, ORF3 surprisingly aligned with the genomic 
position of Bam35 gp6, which is a LexA-type activator of late gene 
transcription. BLAST analysis also suggested that ORF2 is involved in gene 
regulation, which is particularly interesting since a LexA-type regulator 
immediately follows it. Additionally, if the DNA polymerase is indeed regulated 
by the phage itself, it would involve a regulator encoded at the beginning of 
the genome acting upon the opposite extremity, a rare phenomenon in 
phages. It should be noted that SOS-induction experiments using UV 
stimulation did not induce lysogenic Wip1 virion production. 
Yet another particularly intriguing region of the genome includes Wip1 
ORF22, ORF23, and ORF24. Wip1 ORF22 is predicted to be a putative spike 
complex protein as it shares 51.3% sequence identity with Bam35 gp28, a 
homolog for PRD1 trimeric spike protein P5. Bam35 gp28 is followed by gp29, 
a 293 amino acid protein that also resides on the phage surface. If Wip1 and 
AP50 genomic organization both align with that of Bam35c, then a putative 
spike complex protein should follow. Interestingly, in Wip1 and AP50, the 
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genes downstream the P5 homolog are located in a highly variable region and 
do not share sequence identity with any Bam35 ORFs. Despite the lack of 
homology, we predicted that Wip1 gene products 23 and 24 (totaling 235 
amino acids together) were putative spike complex proteins based on their 
strikingly similar gene cassette alignment both upstream and downstream of 
this region. Finally, we were intrigued by the observation that while Wip1 
ORF24 shares 51% sequence identity with AP50 ORF29, Wip1 ORF23 is a 
unique gene that does not share sequence homology to any other known 
genes, tectiviral or otherwise.  
 
6. Wip1 p23 and p24 form a stable complex 
Genomic analysis predicted three Wip1 proteins, p22, p23, and p24 
(indicated in red in Figure 12) to be possible candidates for the Wip1 spike 
complex. We developed expression and purification schemes for the his-
tagged constructs of all three viral proteins. However, the separately 
expressed his-p23 and his-p24 constructs resulted in extremely low yields of 
soluble protein due to the formation of inclusion bodies (Figure 13). Curiously, 
when his-p23 and p24 were co-expressed together, significantly higher yields 
of soluble protein were generated, suggesting that his-p23 and p24 assist 




Figure 13. SDS-PAGE of soluble and insoluble recombinant protein 
fractions 
Recombinant his-tagged constructs of viral proteins were built and 
expressed using methods described. Induced cell cultures underwent 
treatments to extract both soluble proteins and insoluble proteins from 
inclusion bodies (using lysozyme, 14.7 kDa). Major bands for his-p23 
(18 kDa) and his-p24 (18.8 kDa) are revealed in the inclusion body 
extractions for each separate construct. In contrast, major bands for 
his-p23 (18 kDa) and p24 (13.6 kDa) are visible in the soluble fraction 
for the his-p23 + p24 co-expression construct. 
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Subsequent recombinant protein purification steps also revealed his-
p23 and p24 interactions. Nickel-nitrilotriacetic acid (Ni-NTA) resins are used 
for rapid one-step purification of proteins containing a His-tag by preferentially 
binding to histidine residues. After co-expressed his-p23 and p24 proteins 
were processed through a stringently washed Ni-NTA column, both were 
eluted together despite the fact that p24 was not his-tagged (Figure 14).  
In a second purification step, the Ni-NTA elution was processed through 
an ion exchange column that separates molecules based on their charge. 
Distinct peaks were observed and analyzed by SDS-PAGE, revealing unique 
protein populations in each peak. This indicates that ion exchange purification 
was successful in separating proteins and protein complexes of different 
charges. Again, both proteins were observed together in the same ion 
chromatography fractions despite the fact that his-p23 and p24 exhibit 
drastically different pIs of 8.4 and 4.9, respectively (Figure 14). The 
observation that neither purification scheme separated the two proteins 









Figure 14. Ion chromatogram and SDS-PAGE of select fractions 
The Ni-NTA eluate containing both his-p23 and p24 (Lane 1) was 
further purified by charge using ion exchange chromatography. The 
distinct peaks were evaluated with SDS-PAGE, which revealed the 
presence of his-p23 alone in Peak 1 and the presence of his-p23 and 






Figure 15. SDS-PAGE of final stocks of purified recombinant Wip1 
proteins 
Following expression and purification methods as described, the 
recombinant his-tagged Wip1 proteins were then measured using 
standard BSA assays. Protein solutions were diluted to concentrations 
of 250 µg/ml for single protein samples (his-p22; his-p23; his-p24) and 
500 µg/ml for co-expressed protein samples (his-p23 + p24). SDS-
PAGE analysis of these protein samples revealed purification to near 
homogeneity. The samples shown here are the exact samples used in 
the following protein overlay-based inhibition assays. 
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7. Wip1 p23 is a receptor-binding protein 
The purified recombinant proteins (Figure 15) were measured by 
standard Bovine Serum Albumin (BSA) immunoenzymetric assays. Protein 
stocks were diluted to concentrations of 250 µg/ml for single protein samples 
(his-p22; his-p23; his-p24). The co-expressed protein complex sample (his-
p23 + p24) was diluted to 500 µg/ml to account for the presence of two 
different proteins. These recombinant protein stocks were then used in a Wip1 
activity inhibition assay, which consisted of overlaying the viral proteins on top 
of B. anthracis ∆Sterne growing in soft agar plates before adding a final 
overlay of infectious Wip1 phage (Figure 16). The rate of infectivity inhibition 
was calculated as the percentage of inactivated phage (# total original phage 
– # infectious phage titered after incubation with recombinant protein) out of 
total phage (as determined by a buffer only control). 
 




His-p23 was shown to competitively inhibit Wip1 infectivity up to 100% 
in a dose-dependent manner while his-p22 and his-p24 had no effect on 
phage infectivity (Figures 17 and 18). This finding suggests that Wip1 p23 is a 
receptor-binding protein. The addition of his-p23 would occupy the available 
receptors on the host surface and prevent other ligands such as Wip1 phage 
from binding. Interestingly, the his-23 plus p24 complex exhibited even higher 
inhibition levels than his-p23 alone, a finding that may be explained by either 
increased protein stability or enhanced activity of the receptor binding 
complex. 
The possibility that recombinant his-p22 and his-p24 may not possess 
their full biological activity because of the linked histidine should be noted. 
However, issues for his-p24 concerning potential misfolding or activity 
interference caused by a histidine tag are partially addressed by the properly 
folded and non-his-tagged p24 co-expressed with the his-p23 + p24 complex. 
 
Figure 17. Photograph of Wip1 inhibition assay results 
Results of the Wip1 inhibition assay using recombinant viral proteins at 




Figure 18. Wip1 inhibition of infectivity by recombinant Wip1 proteins 
Wip1 phage was assayed for inactivation by recombinant viral proteins 
at various concentrations. Protein concentrations are indicated per 
protein. His-p23 (red) and the his-p23 + p24 complex (purple) 
inactivated Wip1 infectivity by up to 100% in a dose-dependent manner. 
His-p22 (blue) and his-p24 (green) did not affect phage activity. Bars 




In a second Wip1 inhibition assay, we generated rabbit polyclonal 
antisera against Wip1 his-p23. The resulting anti-his-p23 antibodies were 
tested for neutralization of phage activity. Various dilutions of antibody serum 
were pre-incubated with Wip1 phage before adding B. anthracis ∆Sterne 
bacteria to the mixture. After centrifugation pelleted the bacterium-bound 
phage, any unbound or antibody-bound phage remaining in the supernatant 
was removed. The pelleted cells were plated to reveal the titer of bacterium-
bound phage. Adsorption inhibition was calculated as the percentage of un-
adsorbed phage (# total phage - # bacterium-bound phage) out of total phage 
(as determined by a buffer only control). 
The anti-his-p23 antibodies reduced Wip1 adsorption by up to 90% in a 
dose-dependent manner. Pre-bleed serum did not have an effect on Wip1 
activity (Figure 19). This suggests that Wip1 p23 protein resides on the phage 
surface and is consistent with the finding that it is a receptor binding molecule. 
Anti-his-p23 antibodies would bind to p23 on the surface of Wip1 virions, 
preventing the phages from binding to and infecting its host. 
It should be noted, however, that the neutralizing effect of anti-his-p23 
serum on Wip1 activity was much weaker compared to that of anti-gp28 or 
anti-gp29 serum on Bam35 activity. At a mere 20x dilution, anti-his-p23 
antibody inactivation measured below 20% (Figure 19). In contrast, anti-gp28 
and anti-29 antibodies did not demonstrate phage inactivation rates below 




Figure 19. Anti-his-p23 antibody neutralization of Wip1 activity 
Polyclonal antibodies were generated against his-p23 and tested for 
neutralization of Wip1 activity using methods described. After pre-
incubation with phage, anti-his-p23 (closed circles) inhibited Wip1 
adsorption to B. anthracis ∆Sterne by up to 90% in a dose-dependent 
manner. Pre-bleed serum (open circles) did not affect Wip1 adsorption 
activity. Bars represent standard error of at least 3 experiments. 
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One explanation for this difference is the possibility that his-p23 is a 
poor antigen that generated a weak immunogenic response. To test this 
possibility, an indirect ELISA assay determined that the polyclonal antisera 
against his-p23 demonstrated reasonable immunogenic strength (reading of 
Abs=1 at 1:2000 dilution). However, although the antisera was reactive 
against recombinant his-tagged p23, it still may not exhibit the same level of 
immunogenicity against non-his-tagged p23 on the Wip1 virion. 
Additional observations led us to a second possible explanation. When 
the serum-phage-bacterium mixtures were pelleted to remove unbound and 
antibody-bound phage, the adsorption inactivation rate was ~80%. Yet, when 
the serum-phage-bacterium mixtures were plated directly without pelleting, the 
same concentration of anti-sera reduced infectivity by only ~40% (Figure 20). 
From this finding, we hypothesized two possibilities: that Wip1 phage 
association with the polyclonal antibodies is reversible and/ or that Wip1 
phage has a higher affinity for its host receptor than for the polyclonal 
antibodies generated against his-p23. In an assay with such kinetics, antibody-
bound phage plated with bacteria would disassociate from the antibodies over 
time and preferentially bind to and infect its host instead. In contrast, plating 
only the pelleted bacterium-bound phage would remove the population of 






Figure 20. Comparison of anti-his-p23 serum neutralization of Wip1 
adsorption and infection 
Anti-his-p23 antibodies were tested for inhibition of both Wip1 
adsorption (closed circles) and infection (open circles) using the same 
serum dilution. While anti-his-p23 serum inhibited initial adsorption 
(~80%), infectivity was inhibited to a much lesser degree (~40%). This 
suggests that the effects of antibody neutralization become less 
pronounced over time as phage dissociate from the antibodies and 
preferentially bind to and infect their hosts. 
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8. Wip1 p23 binding is specific to B. anthracis 
 To further understand the interaction between Wip1 proteins and 
bacterial surfaces, the purified his-tagged viral proteins were tested for surface 
labeling of select bacterial strains using indirect immunofluorescence 
microscopy. After adherence to a microscope slide, fixed bacterial cells were 
first labeled with his-tagged recombinant viral proteins, then with anti-his 
antibodies from mice, and finally with red-fluorescent anti-mouse antibodies 
(Figure 21). Cells were also stained with 4’,6-diamidino-2-phenylindole (DAPI), 
a blue-fluorescent stain that binds strongly to dsDNA. 
 




Figure 22 illustrates that both his-p23 and the his-p23 + p24 complex 
bind to the surface of B. anthracis ∆Sterne. These observations are consistent 
with Wip1 p23’s function as a receptor-binding protein. Surprisingly, the 
proteins bound all mid-log phase ∆Sterne uniformly but bound only a 
subpopulation of stationary phase ∆Sterne. His-p22 and his-p24 were unable 
to bind either phase of ∆Sterne, further suggesting that Wip1 p22 and p24 are 
not involved with Wip1 adsorption. As expected, no Wip1 proteins bound the 
surface of B. cereus ATCC 4342, which Wip1 neither infects nor adsorbs to. 
In Figures 23 and 24, the specificity of the binding of his-p23 and the 
his-p23 + p24 complex to B. anthracis is shown by additional indirect 
immunofluorescence microscopy. The recombinant viral proteins successfully 
bound B. cereus CDC32805, the only B. cereus strain in our host range 
analysis that supported Wip1 infection and adsorption (Table 4). In contrast, 
the his-tagged proteins were unable to bind the surface of B. cereus strains 
CDC13100, CDC13140, ATCC 10987, and NRL 569. They were also unable 
to bind B. thuringiensis strains HD1 and HD73. None of these unlabeled 
strains support either Wip1 infection or adsorption. These findings suggest that 
his-p23 does not bind to just any gram-positive bacterial surface, but binds 
very specifically to the bacterial hosts that support Wip1 infection and 












Table 4. Comparative table of Wip1 host range and his-p23 binding 
Bacterial strains that support Wip1 infectivity and adsorption showed 
positive labeling by immunofluorescent his-p23 and his-p23 + p24 
complex. Bacterial strains resistant to Wip1 activity were not labeled by 
his-p23 or his-p23 + p24 complex. The lower limit of detection of 
infectivity is indicated by “< 10”, while the lower limit of detection of 






Figure 23. Indirect immunofluorescence microscopy using his-p23 and 




Figure 24. Indirect immunofluorescence microscopy using his-p23 and 
the his-p23 + p24 complex (cont’d)        1000X magnification 
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9. B. anthracis receptor for Wip1 requires Sap for cell wall presence 
 Based on Wip1 phage’s high specificity for B. anthracis, we 
hypothesized that the cellular receptor for Wip1 is a cell wall component 
unique to the surface of B. anthracis. Teichoic acids and S-layer 
carbohydrates were not considered to be receptor candidates because they 
are not present on the surface of B. anthracis [68]. The major repeating 
peptidoglycan components were also eliminated as candidates because they 
are universally present on all gram-positive bacteria and would not confer host 
range specificity. In order to identify the cellular Wip1 receptor, we focused our 
attention on cell wall associated proteins and carbohydrates. 
 Cell wall associated carbohydrates from B. anthracis ∆Sterne and B. 
cereus ATCC 4342 were extracted and purified using a hydrofluoric acid 
treatment as described in the Methods section. These surface carbohydrate 
fractions were resuspended at a concentration of 8 mg/ml. To study the effect 
of the carbohydrates on Wip1 activity, the carbohydrate samples were pre-
incubated with various dilutions of phage before the mixtures were titered on 
B. anthracis ∆Sterne (Figure 25). In this assay, carbohydrate to phage ratios 
ranged from 0.8 mg carbohydrate sample per 100 PFU Wip1 to 0.8 mg 
carbohydrate sample per 100,000 PFU Wip1. Phage infectivity was calculated 
as the percentage of infectious phage out of total phage (as determined by a 




Figure 25. Effect of surface carbohydrates on Wip1 infectivity 
Extracted cell wall associated carbohydrates from B. anthracis ∆Sterne 
and B. cereus ATCC 4342 were tested for their effect on Wip1 
infectivity. Various dilutions of phage were pre-incubated with 
carbohydrate samples before being plated out on ∆Sterne. Neither 
carbohydrate fraction had an effect on Wip1 infectivity in this assay. 




 Neither carbohydrate sample from the Bacillus strains demonstrated an 
effect on Wip1 infectivity (Figure 25). However, these results do not 
necessarily indicate that cell wall associated carbohydrates are not the Wip1 
receptor. It should be noted that the carbohydrate extracts were not tested for 
composition and could possibly lack purity that affected assay results. 
Furthermore, it is very possible that the assay was not sensitive enough to 
detect any inhibitory effect of the carbohydrate samples. In order for the assay 
to detect competitive inhibition, there must be a high enough concentration of 
receptors to occupy all 11 labile spikes on each Wip1 virion. The results of the 
carbohydrate inhibition assay were thus deemed inconclusive. 
 In order to determine if the Wip1 receptor is a bacterial surface protein, 
we studied the effect of bacterial protease treatment on phage adsorption. 
Proteases (Pronase and protease K) were incubated with bacterial cells for 1 
hour and then removed with multiple washes. Treated and untreated B. 
anthracis ∆Sterne and B. cereus ATCC 4342 cells were incubated with Wip1 
phage for 5 or 20 minutes before centrifugation and spin filtration. Unbound 
phages present in the supernatant were titered on ∆Sterne. Bound phage was 
calculated as the percentage of adsorbed phage (# total phage - # titered 
unbound phage in supernatant) out of total phage (as determined by a buffer 
only control). Adsorption rates measured over 99% for both protease treated 
and untreated B. anthracis cells. The observation that protease treatment of 
the bacterial surface had no effect on adsorption suggests that the Wip1 




Figure 26. Adsorption to protease treated bacteria 
B. anthracis ∆Sterne and B. cereus ATCC 4342 were treated with and 
without protease before subsequent washings and incubation with Wip1 
phage. Adsorption was measured at 5 and 20 minutes post infection 
time points. Results indicated no effect on adsorption from protease 
treatment of cells. Bars represent standard error calculated from at 




 From personal communications, we learned that the closely related 
phage AP50 does not infect B. anthracis SAP- mutants. SAP is the gene 
encoding Sap protein, the 94 kDa B. anthracis surface array protein that forms 
the S-layer during exponential growth [69]. The gene csaB lies next to the SAP 
operon and is required for Sap protein retention on the cell wall. Wip1 was 
tested for infectivity and adsorption on both B. anthracis Sterne SAP- and B. 
anthracis csaB- strains. Infectivity was measured by directly titering Wip1 
phage on bacterial soft agar plates. Adsorption was calculated as the 
percentage of bound phage (# total phage - # unbound phage in supernatant) 
out of total phage. Both mutants were resistant to Wip1 infection and 
adsorption (Table 5). This finding indicates that the B. anthracis receptor for 
Wip1 requires Sap protein for its presence on the cell wall. 
 Indirect immunofluorescence microscopy using his-tagged viral proteins 
showed that his-p23 and the his-p23 + p24 complex were unable to bind B. 
anthracis Sterne SAP- mutants (Figure 27). This is consistent with the 
hypothesis that this mutant lacks the Wip1 receptor on its surface. 






Figure 27. Indirect immunofluorescence microscopy on B. anthracis 
Sterne SAP- mutants using his-tagged Wip1 proteins 
 1000X magnification 
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 In order to test whether the Sap protein itself was the Wip1 receptor, we 
performed a pull-down assay using receptor-binding complex his-p23 + p24 as 
the affinity ligand. Cell wall associated proteins were extracted from mid-log 
phase B. anthracis ∆Sterne and B. cereus ATCC 4342 by incubating the cells 
with PlyG lysin in a 30% raffinose solution. While PlyG normally lyses Bacillus 
cells, the 30% raffinose solution keeps the protoplasm intact, preventing the 
release of cytoplasmic proteins into solution. After the protoplasms were 
pelleted, the cell wall associated proteins in the supernatant were applied to a 
Ni-NTA column pre-loaded with the receptor-binding complex his-p23 + p24. 
Fractions from the column flow-throughs, washes, and elution were collected, 
concentrated using TCA precipitation, and analyzed with SDS-PAGE. 
 Sap protein was revealed in fractions from mid-log phase B. anthracis 
∆Sterne but not B. cereus ATCC 4342. However, the Sap protein was not 
present in the elution, indicating that Sap did not bind to the receptor-binding 
complex in the pull-down assay (Figure 28). Surprisingly, the elutions from 
both ∆Sterne and ATCC 4342 pull-down assays contained two non-viral 
proteins measuring between 30 to 40 kDa. However, these proteins were not 
pulled down during the assay as they were revealed to be present in TCA 
concentrated samples of purified his-p23 + p24 complex stock. Since the 
recombinant proteins were expressed using E. coli cells, these two proteins 






Figure 28. Pull-down assay using receptor-binding complex his-p23 + 
p24 
Cell wall associated proteins from mid-log phase B. anthracis ∆Sterne 
and B. cereus ATCC 4342 were applied to Ni-NTA columns pre-loaded 
with the receptor-binding complex his-p23 + p24. Fractions of the flow-
throughs (F), washes (W), and elution (E) were collected and analyzed 
with SDS-PAGE. 26 kDa PlyG (orange arrows) was used in the surface 
protein extraction method. 94 kDa Sap protein (blue arrow) was 
identified in ∆Sterne flow-through and wash fractions, but was not 
eluted with the receptor-binding complex. The elution fraction revealed 
two proteins between 30 - 40 kDa that were also present in the his-p23 
+ p24 protein stock sample. 
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 The results of the pull-down assay strongly suggest that Sap protein is 
not a receptor for Wip1 phage. The lack of proteins pulled down in the assay 
was also consistent with the previous finding that the receptor is not a protein. 
Although the cellular receptor for Wip1 has yet to be identified, it has been 
thus characterized as a cell wall component specific to the B. anthracis 


















 Isolated relatively recently in 2003, Wip1 phage is the newest member 
of the rare Tectiviridae family. Tectiviruses have been of particular interest due 
to PRD1’s structural similarities to the mammalian adenovirus and AP50’s high 
specificity for the biowarfare pathogen B. anthracis. Interestingly, Wip1 also 
exhibits a narrow host range that is highly specific for B. anthracis, more so 
than the current diagnostic standard Wγ phage [1]. In the present study, we 
determined with adsorption assays that specificity to B. anthracis is mediated 
by Wip1’s receptor-binding ligand. Here, we reported the unusual Wip1 
genomic sequence and identified Wip1 gene product 23 as a receptor-binding 
protein. We also showed that Wip1 p23 forms a complex with another viral 
protein p24 and binds very specifically to B. anthracis. Ultimately, we 
demonstrated that Wip1 is a unique phage and characterized the molecules 








1. Wip1 specificity for B. anthracis is mediated by specificity of 
adsorption 
 Wip1 exhibits a highly specific tropism for B. anthracis and does not 
infect closely related Bacillus strains such as B. cereus ATCC 4342. Although 
tropism is often determined by receptor binding, this is not always the case. 
For example, the poliovirus receptor is not sufficient to determine poliovirus 
tropism to the brain and spinal cord since this protein receptor is produced on 
a broad range of animal tissues. Instead, restriction of poliovirus replication is 
thought to occur after viral binding and entry [76, 77]. In another case, electron 
microscopy showed that Wγ phage binds to the surface of B. thuringiensis 97-
27, a strain that it does not infect [61]. This finding indicates that the Wγ 
receptor GamR is sufficient for binding but not for DNA delivery. 
 By testing closely related Bacillus strains for Wip1 adsorption, we 
demonstrated that Wip1 binding is very specific to B. anthracis (Table 2). This 
strongly suggests that Wip1 specificity for B. anthracis infection is indeed 
mediated by specificity of adsorption. Additionally, adsorption kinetics 
indicated that Wip1 binding to its host surface is both specific and rapid. B. 
anthracis ∆Sterne bound 80% of virus particles within one minute (Figure 9). 
This rapid adsorption is also observed during Bam35 binding to B. 
thuringiensis HER1410 [39]. However, given that the Bam35 receptor is a 
major peptidoglycan component that dominates the cell surface, these kinetics 
are less surprising for Bam35 than for Wip1. 
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2. Wip1 sequence exhibits both tectiviral genome conservation and 
notable distinctions 
 We sequenced and examined the Wip1 sequence and determined that 
it shares significant similarities to the genomes of other gram-positive infecting 
tectiviruses. Its genome length of 14,319 bp is close to other tectiviral genome 
lengths ranging from 14,398 bp (AP50) to 14,925 bp (PRD1). The map of 
Wip1’s 27 putative ORFs reveal a tightly packed organization with short genes 
and few noncoding regions, characteristic of all tectiviral genomes (Figure 12). 
The Wip1 genome is predicted to encode a Lex-A-type regulator, five DNA 
packaging/ assembly genes, a DNA delivery gene, two lysins, and at least four 
capsid/ spike genes. The size, sequence, and/ or organization of these ORFs 
are remarkably similar to that of other gram-positive infecting tectiviruses. 
Wip1 is most closely related to B. anthracis specific phage AP50, with 15 out 
of 27 ORFs sharing sequence identity of at least 75% to corresponding AP50 
genes. 
While the central section of the Wip1 genome exhibits some 
conservation to other tectiviral genomes, the extremities displayed highly 
unusual features. This was rather unexpected considering that all other gram-
positive infecting tectiviruses exhibited significant conversation throughout the 
entire lengths of their genomes. In fact, Bam35, GIL01, and GIL16 share 86 to 
99% sequence similarity. In contrast, Wip1 is missing the first 5 conserved 
ORFs and has replaced them with unique genes for ORFs 1 through 4. Most 
interestingly, Wip1 encodes its DNA polymerase at the very end of its genome 
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on the negative strand whereas all other tectiviruses including PRD1 encode 
its polymerase early in the sequence on the positive strand. Furthermore, 
many of these genes are not only unique within the group but also unique 
within the entire known database of proteins. 
Notably, the GC content at both extremities is lower than the 
percentage observed in the central region of the genome and more precisely, 
in all the ORFs that share homology with AP50 (Table 3). The 5’ end of the 
Wip1 genome encodes ORFs 1 through 4, which have GC contents of 29.5%, 
30.7%, 25.7%, and 25.7%, respectively. The opposite 3’ end encodes ORF27 
which has a GC content of 29.7%. In contrast, the genes located at the center, 
such as ORF18 and ORF19, have GC contents of 43.1% and 44.8%, 
respectively. Intergenic spaces at the extremities are also larger than those at 
the central section of its own sequence and what is observed for other 
tectiviral genomes. These observations point to the possibility of a different 
origin for the genome extremities of Wip1. The combination of conservation 
and deviation exhibited could indicate that Wip1 is an evolutionary hybrid 







3. Wip1 receptor-binding ligand p23 is a unique protein 
 The identification of Wip1 p23 as a receptor binding protein is very 
interesting because it is a unique protein with no homology to any other known 
proteins. It is particularly surprising because ORF23 shares no sequence 
identity with AP50, a closely related tectivirus with a similar host range that is 
also highly specific to B. anthracis. Genomic analysis showed that the overall 
Wip1 genome shares significant similarities to the AP50 genome in ORF size, 
sequence, and organization. In fact, the genes neighboring Wip1 ORF23 
display this conservation. ORF22 (291 residues) shares 84% sequence 
identity with AP50 ORF27 (304 residues) and ORF24 (118 residues) shares 
51% sequence identity with AP50 ORF29 (118 residues). 
Another interesting observation is that AP50 ORF28, which is located in 
the corresponding genomic position to Wip1 ORF23, is the gene that harbors 
one of two sequence mutations that differentiate isolates AP50t, which 
produces turbid plaques, and AP50c, which produces clear plaques [41]. 
Generally, clear plaques are formed when the host is completely susceptible 
to the phage while turbid plaques are formed if the host is partially resistant to 
the phage (e.g. if 10% of the cells survive infection). The other mutation is 
located in the non-coding region upstream of ORF1. Furthermore, AP50 
ORF28 and Wip1 ORF23 are located at a highly variable region of their 
respective genomes. On the one hand, it is not too surprising that the Wip1 
receptor-binding domain ORF23 exhibits sequence diversity. On the other 
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hand, it is rather unusual that two closely related tectiviruses with a similar 
host range have evolved uniquely different receptor binding proteins. 
 
4. A proposed function for Wip1 p24 
A notable observation is that the his-p23 + p24 complex exhibited 
higher competitive inhibition than his-p23 alone (Figure 18), suggesting that 
p24 somehow complemented or enhanced his-p23 binding activity. This 
enhancement could result from simply protecting his-p23 proteins from 
degradation. However, we were careful to use fresh protein stocks in the 
assay. Considering that the inhibition rate of his-p23 was dose-dependent, the 
increased inhibitory activity from the complex sample could simply result from 
higher amounts of the his-p23 protein. However, SDS-PAGE analysis of the 
recombinant protein stocks used in the assay (Figure 15) showed that this was 
not the case. 
Another more interesting possibility is that p24 plays a secondary but 
complementary role in Wip1 binding. The adsorption of phage to the gram-
positive bacterial surface has been suggested to occur in two stages. The first 
step involves reversible binding to general recognition molecules on the cell 
surface. This weak interaction allows the virion to stay close to the bacterial 
surface while diffusing across space. The second step involves colliding with a 
specific receptor in an irreversible manner. The seahorse-like structure for 
PRD1 receptor-binding protein P2 consists of multiple domains with different 
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purported functions [4]. In one P2 model, the fin-shaped domain is proposed 
to make initial contacts by scanning the host surface in order to bring the 
receptor-binding domain closer to its receptor. It is possible that Wip1 p24 is 
such a spike complex domain with non-specific, reversible surface scanning 
properties. 
 
5.  Considerations regarding the Sap-dependent cellular receptor 
The inability of Wip1 phage to adsorb to or infect B. anthracis Sterne 
SAP- and csaB- mutants indicated that the cellular receptor requires Sap 
protein on the cell surface. The SAP gene encodes the Sap protein and the 
neighboring csaB gene is involved in anchoring Sap protein to the cell wall. 
The observation that Wip1 binding is Sap dependent led to many questions. 
First, we wondered about Wip1 adsorption to and his-p23 binding to 
stationary phase B. anthracis ΔSterne cells. In B. anthracis, Sap decorates the 
bacterial surface only during exponential growth and is subsequently replaced 
by S-layer protein EA1 upon entering stationary phase [71]. Adsorption assays 
were conducted using stationary B. anthracis ΔSterne cells and, yet, we 
observed rapid adsorption of 80% of virions after one minute and up to 99% 
after 10 minutes (Figure 9). Similarly, indirect immunofluorescence microscopy 
showed his-p23 binding to fixed stationary phase ΔSterne (Figure 22). 
Interestingly, the viral ligand was only able to bind to a subpopulation of 
stationary phase ΔSterne but was able to bind all mid-log phase ΔSterne. 
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Additionally, the signal from his-p23 labeling was noticeably stronger for mid-
log phase ΔSterne than for stationary phase cells. 
The ability of stationary phase B. anthracis lacking Sap protein to 
adsorb the Wip1 receptor-binding ligand could possibly be explained by the 
highly flexible regulatory mechanism of SAP and ea1 expression. Although 
Sap is replaced by EA1 during stationary phase, it was also observed that Sap 
is readily expressed as soon as stationary phase cells were resuspended in 
fresh medium [71]. It should be noted that while the indirect 
immunofluorescence microscopy methods involved cell washing before 
fixation, the adsorption assay did not involve any wash steps, only the addition 
of propagated phage stored in a mixture of BHI media and buffer. As flexible 
as sap regulation may be, it remains curious that unwashed stationary B. 
anthracis cells were observed to adsorb 80% of virions in one minute. 
A second question we wondered was whether Sap protein itself was the 
actual receptor. Although the protease treatment assay seemed to suggest 
that the receptor was not proteinaceous in nature, the new considerations 
regarding the rapid production of Sap made this assay inconclusive. However, 
Sap protein extracted from the surface of mid-log phase B. anthracis ΔSterne 
did not exhibit affinity to the receptor-binding complex in the pull down assay. 
While the protease assay was deemed inconclusive in light of new 
observations, the pull down assay results still indicated that Sap was not a 
receptor for the Wip1 his-p23 + p24 complex. 
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A third question we asked was regarding the nature of the Sap 
dependent receptor. Curiously, the S-layer for B. anthracis is not decorated 
with carbohydrate residues and Sap layer-associated proteins have not been 
described. While the receptor has yet to be identified, it would be very 
interesting indeed to characterize a B. anthracis-specific cell wall element that 
requires Sap protein for availability on the cell surface. 
 
  
6.  Wip1 phage potential as a diagnostic tool for B. anthracis 
The Wip1 phage and its receptor-binding ligand exhibit promise as bio-
defense tools in the detection of the Category A pathogen B. anthracis. We 
demonstrated that not only does Wip1 infect B. anthracis with high specificity, 
but it also binds to its surface in a manner that is remarkably rapid and exhibits 
high affinity. Indirect immunofluorescence microscopy demonstrated that the 
Wip1 receptor-binding p23 and the p23+p24 complex detect and bind B. 
anthracis with specificity that seems to match its narrow host range. In addition 
to high specificity, we propose that the receptor-binding p23 exhibits higher 
affinity for its receptor than to even polyclonal antibodies generated against it. 
These characteristics that we report here make Wip1 and its receptor-binding 
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